Parkinson's disease trials recruiting in Alabama

All Parkinson's disease trials nationally

Cities in Alabama

Recruiting trials in Alabama

• A Study of Buntanetap in Participants With PD
  NCT07284784 · Phase: Phase 2, Phase 3 · Ages: 40 Years to 85 Years · Sex: All (male and female) · Alabama: Birmingham
• A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
  NCT06976268 · Phase: Phase 2, Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · Alabama: Birmingham
• A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
  NCT07174310 · Phase: Phase 3 · Ages: 50 Years to 85 Years · Sex: All (male and female) · Alabama: Birmingham
• Black and African Americans Connections to Parkinson's Disease (BLAAC PD)
  NCT06719583 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Alabama: Birmingham
• Investigating Inhibitory Control Networks in Parkinson's Disease
  NCT04735458 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Alabama: Birmingham
• Low Voltage Electrical Stimulation for Depression in Parkinson's Patients
  NCT06467695 · Phase: Not applicable (e.g. observational or device study) · Ages: 19 Years to 65 Years · Sex: All (male and female) · Alabama: Mobile
• Neurophysiological, Behavioral, and Cognitive Networks in Movement Disorders
  NCT04061135 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Alabama: Birmingham
• PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
  NCT04477785 · Phase: Not specified · Ages: 30 Years and older · Sex: All (male and female) · Alabama: Birmingham
• Parkinson's Foundation PD GENEration Genetic Registry
  NCT04994015 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Alabama: Birmingham
• Sensory Filtering in the Human Basal Ganglia as a Mechanism of Parkinson's Disease
  NCT05482126 · Phase: Not specified · Ages: 18 Years to 89 Years · Sex: All (male and female) · Alabama: Birmingham
• Stimulus-Evoked Directional Field Potentials to Guide Subthalamic and Pallidal DBS for PD
  NCT06169852 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 89 Years · Sex: All (male and female) · Alabama: Birmingham
• The University of Alabama at Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy
  NCT03457493 · Phase: Phase 1, Phase 2 · Ages: 30 Years and older · Sex: All (male and female) · Alabama: Birmingham
• Using taVNS to Modulate Cardiovascular Function in Individuals With Neurologic Disease
  NCT07557706 · Phase: Phase 1 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Alabama: Birmingham